ConductScience.org, home

Paper36911456

Successful Rapid Desensitization of a Pediatric Multiple Sclerosis Patient with Anaphylaxis to Ocrelizumab.

Karaaslan HBG and 7 others. Ann Indian Acad Neurol, 2022. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Successful Rapid Desensitization of a Pediatric Multiple Sclerosis Patient with Anaphylaxis to Ocrelizumab. Papers, record 36911456. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911456

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Successful Rapid Desensitization of a Pediatric Multiple Sclerosis Patient with Anaphylaxis to Ocrelizumab.
PubMed
Journal
Ann Indian Acad Neurol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2023-10-31
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karaaslan HBGHatice B G
2Aydemir SSezin
3Amirov CBCeren B
4Dilek TDTugce D
5Bayramli ZZerengiz
6Saltik SSema
7Kiykim AAyca
8Cokugras HHaluk

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125754718Hypersensitivity to biological agents-updated diagnosis, management, and treatment.J Allergy Clin Immunol Pract2015https://conductscience.org/library/papers/25754718PubMed
229275977Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.Lancet Neurol2018https://conductscience.org/library/papers/29275977PubMed
335222433Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe.Front Immunol2022https://conductscience.org/library/papers/35222433PubMed
433202059Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.Br J Clin Pharmacol2021https://conductscience.org/library/papers/33202059PubMed
530844611Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies.Mult Scler Relat Disord2019https://conductscience.org/library/papers/30844611PubMed
615316518Clinical features and severity grading of anaphylaxis.J Allergy Clin Immunol2004https://conductscience.org/library/papers/15316518PubMed
733224101B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation.Front Neurol2020https://conductscience.org/library/papers/33224101PubMed
832496608Medical algorithm: Diagnosis and treatment of drug hypersensitivity reactions to biologicals.Allergy2020https://conductscience.org/library/papers/32496608PubMed
929518427Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.J Allergy Clin Immunol2018https://conductscience.org/library/papers/29518427PubMed

Download CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36911456

GET https://conductscience.org/api/papers/v1/36911456/authors